Oncology Where old pathways to innovative cancer care fall short, a n... Ignoring half the people in the world cannot be good for business.
Views & Analysis The home advantage in cancer care The optimal cancer care pathway for this complex disease outside the hospital.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
